Login / Signup

Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab.

Robert N StuverSantosha A VardhanaAkshay S BedmuthaKarmela Kim ChanRosna Mirtcheva-TrochevaAnton NosovHeiko SchöderAlison Moskowitz
Published in: Leukemia & lymphoma (2023)
Keyphrases
  • hodgkin lymphoma
  • case report
  • high dose
  • advanced non small cell lung cancer
  • epidermal growth factor receptor